Amyloid-β Inhibiting Peptides: An Innovative Strategy for Alzheimer’s Disease Treatment

Alzheimer’s disease (AD), the most common neurodegenerative disorder, is characterized by the accumulation of amyloid-β (Aβ) plaques, leading to progressive cognitive decline. Targeting Aβ aggregation has become a major therapeutic focus, and peptide-based inhibitors have emerged as a promising appr...

Full description

Bibliographic Details
Published in:	Research in Molecular Medicine
Main Authors:	Sajjad Molavipordanjani, Solmaz Mojarad-Jabali
Format:	Article
Language:	English
Published:	Mazandaran University of Medical Sciences and Health Services 2023-11-01
Subjects:	alzheimer’s disease (ad) peptide-based inhibitors amyloid-β phage display amyloid plaque
Online Access:	http://rmm.mazums.ac.ir/article-1-552-en.pdf

Similar Items

Amyloid-β Peptide-targeting Immunotherapy in Alzheimer Disease: A Systematic Review of Clinical Studies
by: Haideh Mosleh, et al.
Published: (2024-10-01)

Peptides as Potential Therapeutics for Alzheimer’s Disease
by: Samo Ribarič
Published: (2018-01-01)

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
by: Adla Boumenir, et al.
Published: (2019-03-01)

Development of a Low-Molecular-Weight Aβ42 Detection System Using a Enzyme-Linked Peptide Assay
by: Sang-Heon Kim, et al.
Published: (2021-12-01)

Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels
by: Sophia Schedin-Weiss, et al.
Published: (2017-08-01)

Effects of BIS-MEP on Reversing Amyloid Plaque Deposition and Spatial Learning and Memory Impairments in a Mouse Model of β-Amyloid Peptide- and Ibotenic Acid-Induced Alzheimer’s Disease
by: Yu Wang, et al.
Published: (2019-01-01)

Cerebrospinal Fluid β‐Amyloid and τ Levels in Patients With Iatrogenic Cerebral Amyloid Angiopathy, Sporadic Cerebral Amyloid Angiopathy, Alzheimer Disease, and Controls
by: Ulf Jensen‐Kondering, et al.
Published: (2025-08-01)

Degradation of amyloid β-peptides catalyzed by nattokinase in vivo and in vitro
by: Aixin Ni, et al.
Published: (2023-09-01)

Aβ aggregation inhibition via peptide-conjugated gold nanoclusters: Mechanistic insights and therapeutic potential
by: Ye-Cheng Wang, et al.
Published: (2025-06-01)

Novel Monoclonal Antibody Specific toward Amyloid-β Binds to a Unique Epitope within the N-Terminal Region
by: Giavanna Paterno, et al.
Published: (2024-08-01)

Making the final cut: pathogenic amyloid-β peptide generation by γ-secretase
by: Harald Steiner, et al.
Published: (2018-10-01)

Big dynorphin is a neuroprotector scaffold against amyloid β-peptide aggregation and cell toxicity
by: Lucía Gallego-Villarejo, et al.
Published: (2022-01-01)

Anti-amyloid β hydrophobic peptides in Alzheimer’s disease: biomarkers and therapeutic potential
by: Carlos Gutierrez-Merino
Published: (2025-02-01)

Structural Studies Providing Insights into Production and Conformational Behavior of Amyloid-β Peptide Associated with Alzheimer’s Disease Development
by: Anatoly S. Urban, et al.
Published: (2021-05-01)

Phototherapy via Modulation of β‐Amyloid in Combating Alzheimer's Disease
by: Yunhua Zhang, et al.
Published: (2025-05-01)

Multifaceted neuroprotective effects of (-)-epigallocatechin-3-gallate (EGCG) in Alzheimer’s disease: an overview of pre-clinical studies focused on β-amyloid peptide
by: Kumju Youn, et al.
Published: (2022-05-01)

Validation of Fucoxanthin from Microalgae <em>Phaeodactylum tricornutum</em> for the Detection of Amyloid Burden in Transgenic Mouse Models of Alzheimer’s Disease
by: A-Hyeon Lee, et al.
Published: (2021-06-01)

PICALM Regulating the Generation of Amyloid β‐Peptide to Promote Anthracycline‐Induced Cardiotoxicity
by: Mengni Bao, et al.
Published: (2024-08-01)

New insights into the 17β-hydroxysteroid dehydrogenase type 10 and amyloid-β 42 derived cytotoxicity relevant to Alzheimer’s disease
by: Aneta Houfková, et al.
Published: (2025-07-01)

Bacterial Extracellular DNA Promotes β-Amyloid Aggregation
by: George Tetz, et al.
Published: (2021-06-01)

The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer’s disease pathology models
by: Megan J. Lantz, et al.
Published: (2023-05-01)

Inhibition of amyloid-β(16–22) aggregation by polyphenols using replica permutation with solute tempering molecular dynamics simulation
by: Daiki Fukuhara, et al.
Published: (2023-12-01)

Impacts of FDA approval and Medicare restriction on antiamyloid therapies for Alzheimer's disease: patient outcomes, healthcare costs, and drug development
by: Rouen Brockmann, et al.
Published: (2023-04-01)

β-Amyloid Formation, Memory, and Learning Decline Following Long-term Ovariectomy and Its Inhibition by Systemic Administration of Apigenin and β-Estradiol
by: Seyed Behnamedin Jameie, et al.
Published: (2021-05-01)

Novel harmine derivatives as potent acetylcholinesterase and amyloid beta aggregation dual inhibitors for management of Alzheimer’s disease
by: Hongtao Du, et al.
Published: (2023-12-01)

Systematic search for peptide and protein ligands of human serum albumin capable of affecting its interaction with amyloid β peptide
by: E. V. Loktyushov, et al.
Published: (2022-12-01)

Polymeric nanoparticles: A promising strategy for treatment of Alzheimer's disease
by: Yasmina S.M. Elmahboub, MSc, et al.
Published: (2024-06-01)

Nanomaterials in targeting amyloid-β oligomers: current advances and future directions for Alzheimer's disease diagnosis and therapy
by: Shiwani Randhawa, et al.
Published: (2025-04-01)

β-Amyloids and Immune Responses Associated with Alzheimer’s Disease
by: Elizaveta Kolobova, et al.
Published: (2024-09-01)

Vaccination against β-Amyloid as a Strategy for the Prevention of Alzheimer’s Disease
by: Francesca Mantile, et al.
Published: (2020-11-01)

Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer’s disease: a PET substudy interim analysis
by: Gregory Klein, et al.
Published: (2019-12-01)

Amyloid PET Radiopharmaceuticals and Imaging for Clinical and Research Applications in Thailand
by: Tossaporn Siriprapa, et al.
Published: (2023-09-01)

Phosphorylated Aβ peptides in human Down syndrome brain and different Alzheimer’s-like mouse models
by: Sathish Kumar, et al.
Published: (2020-07-01)

Sleep duration, sleep efficiency, and amyloid β among cognitively healthy later-life adults: a systematic review and meta-analysis
by: Chooza Moon, et al.
Published: (2024-05-01)

Alzheimer’s disease: amyloid-based pathogenesis and potential therapies
by: Yixiu Zhou, et al.
Published: (2018-06-01)

The Role of CSF Biomarkers in Discriminating Between Cerebral Amyloid Angiopathy and Alzheimer’s Disease Patients: Systematic Review of Clinical Studies
by: Zahra Razmkhah, et al.
Published: (2024-10-01)

Recent Research Progress in Fluorescent Probes for Detection of Amyloid-β In Vivo
by: Zhen-Yu Zhang, et al.
Published: (2023-11-01)

Intravenously Injected Amyloid-β Peptide With Isomerized Asp7 and Phosphorylated Ser8 Residues Inhibits Cerebral β-Amyloidosis in AβPP/PS1 Transgenic Mice Model of Alzheimer’s Disease
by: Sergey A. Kozin, et al.
Published: (2018-08-01)

Evaluating the inter-species transmission risk of amyloid beta peptide aggregates via ingestion
by: Joshua Raine, et al.
Published: (2024-06-01)

Amyloid β-Peptide Increases Mitochondria-Endoplasmic Reticulum Contact Altering Mitochondrial Function and Autophagosome Formation in Alzheimer’s Disease-Related Models
by: Nuno Santos Leal, et al.
Published: (2020-11-01)